Utility of Oncotype DX Risk Assessment in Patients With Invasive Lobular Carcinoma.

M. Tsai,T. Lillemoe,Marsha J. Finkelstein,Joel E Money,B. Susnik,Erin V Grimm,Sung-Hae L Kang,K. Swenson
DOI: https://doi.org/10.1016/j.clbc.2015.08.001
IF: 3.078
2016-02-01
Clinical Breast Cancer
Abstract:
What problem does this paper attempt to address?